AOD-9604

AOD-9604 is a synthetic peptide fragment corresponding broadly to the C-terminal region of human growth hormone (hGH), a portion of the sequence discussed in the literature in connection with lipid-related activity. It is sometimes referenced in research writing as a growth hormone fragment analog and was designed to correspond to this region of the parent molecule rather than to reproduce the full signaling profile of the intact hormone; any characteristics described in the literature are reported from research models and individual results vary. This catalog entry references AOD-9604 as a single-compound injectable item within the Growth Hormone and Performance category.

AOD-9604 is supplied strictly as a research peptide for laboratory and professional use. It is not approved by the FDA for therapeutic use, and nothing in this reference should be read as a therapeutic, diagnostic, or treatment claim. It is provided for licensed practitioners and qualified researchers for purposes consistent with applicable regulations.

• Investigated in preclinical literature for its proposed role in lipid metabolism and adipose tissue research models (individual results vary)
• Studied in research settings for questions related to metabolic regulation and energy substrate handling (individual results vary)
• Referenced in growth hormone fragment literature as a tool for exploring hGH C-terminal sequence activity apart from the broader signaling profile of the full hormone
• Examined in exploratory research contexts concerning cartilage and connective-tissue biology
• Used as a comparator or reference peptide in studies of growth hormone-derived analogs

Reference handling information only. AOD-9604 is typically supplied as a lyophilized (freeze-dried) powder. Lyophilized peptide is generally stored frozen and protected from light and moisture until reconstitution. For reconstitution, bacteriostatic water (or another diluent selected by the ordering provider) is commonly added gently against the vial wall rather than directly onto the powder, with the vial swirled rather than shaken to support solubility. After reconstitution, peptide solutions are generally kept refrigerated, protected from light, and used within a limited window consistent with good laboratory practice; reconstituted material is not intended to be left at room temperature for extended periods. Always verify vial-specific guidance, diluent compatibility, and laboratory standard operating procedures. Clinical and research protocols, including any dosing, preparation specifics, and applications, are determined solely by the licensed ordering provider; this is reference information for professional and research use only and is not medical advice.

A per-lot Certificate of Analysis, HPLC purity profile, and mass-spectrometry verification are available on request for this product. Ask your account manager for the current lot documentation.

In the published research literature, AOD-9604 has been described as a fragment corresponding to a region of human growth hormone discussed in connection with lipid-related activity, and it has been proposed to interact with pathways involved in lipolysis (the breakdown of stored lipids) and the inhibition of lipogenesis (the formation of new lipid) in preclinical models. A frequently discussed feature in research framing is that the fragment has been described in preclinical reports as associated with these metabolic endpoints apart from the receptor-mediated effects on growth and insulin-like signaling characteristically attributed to the intact hormone. The precise mechanism, receptor interactions, and downstream signaling remain an active subject of investigation, and reported observations are derived from laboratory and preclinical research rather than established clinical outcomes; individual results vary.